iShares U.S. Pharmaceuticals ETFIHE
Type
ETF
Peer group
US equity: Healthcare
Net assets
$1.0B
Expense ratio
0.38%
1-year return
+48.2%
3 years, a year
+19.9%
5 years, a year
+11.9%
12-month yield
1.40%
Holdings
59
What it aims to do.
The iShares U.S. Pharmaceuticals ETF (the Fund ) seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| JNJ Johnson & Johnson | 23.03% |
| LLY Eli Lilly And Company | 21.06% |
| MRK Merck & Co., Inc. | 4.74% |
| PFE Pfizer Inc. | 4.71% |
| RPRX Royalty Pharma Plc | 4.70% |
| BMY Bristol-Myers Squibb Company | 4.63% |
| ZTS Zoetis Inc. | 4.52% |
| BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | 4.35% |
| VTRS Viatris Inc. | 4.35% |
| ELAN Elanco Animal Health Incorporated | 3.32% |
More on IHE.
- IHE overview
- IHE holdings
- IHE risk
- IHE costs
- IHE money in and out
- IHE share classes
- Compare IHE with other funds
Returns after fees, from the fund's SEC filings up to Aug 2026. Past returns are not a promise. Not financial advice.